2462. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Individuals 56 Years of Age and Older

BACKGROUND: The MenACYW-TT conjugate vaccine is a quadrivalent meningococcal vaccine candidate intended for global use in all age groups. This Phase III study evaluated the safety and immunogenicity of the vaccine when compared with a licensed quadrivalent meningococcal polysaccharide vaccine (MPSV4...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeanfreau, Robert, Esteves-Jaramillo, Alejandra, Neveu, David, Jordanov, Emilia, Dhingra, Mandeep S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255455/
http://dx.doi.org/10.1093/ofid/ofy210.2115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255455/
http://dx.doi.org/10.1093/ofid/ofy210.2115

Ejemplares similares